LPL Financial’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $133K | Sell |
10,240
-72
| -0.7% | -$937 | ﹤0.01% | 5061 |
|
2025
Q1 | $109K | Sell |
10,312
-1,184
| -10% | -$12.5K | ﹤0.01% | 4893 |
|
2024
Q4 | $195K | Sell |
11,496
-806
| -7% | -$13.7K | ﹤0.01% | 4705 |
|
2024
Q3 | $286K | Sell |
12,302
-570
| -4% | -$13.2K | ﹤0.01% | 4388 |
|
2024
Q2 | $313K | Sell |
12,872
-469
| -4% | -$11.4K | ﹤0.01% | 4156 |
|
2024
Q1 | $451K | Sell |
13,341
-100
| -0.7% | -$3.38K | ﹤0.01% | 3825 |
|
2023
Q4 | $424K | Sell |
13,441
-570
| -4% | -$18K | ﹤0.01% | 3745 |
|
2023
Q3 | $358K | Buy |
+14,011
| New | +$358K | ﹤0.01% | 3723 |
|
2022
Q2 | – | Sell |
-13,041
| Closed | -$352K | – | 4390 |
|
2022
Q1 | $352K | Buy |
13,041
+3,995
| +44% | +$108K | ﹤0.01% | 3446 |
|
2021
Q4 | $335K | Buy |
9,046
+357
| +4% | +$13.2K | ﹤0.01% | 3596 |
|
2021
Q3 | $415K | Sell |
8,689
-410
| -5% | -$19.6K | ﹤0.01% | 3370 |
|
2021
Q2 | $308K | Buy |
9,099
+3,080
| +51% | +$104K | ﹤0.01% | 3560 |
|
2021
Q1 | $249K | Buy |
6,019
+636
| +12% | +$26.3K | ﹤0.01% | 3585 |
|
2020
Q4 | $234K | Buy |
+5,383
| New | +$234K | ﹤0.01% | 3389 |
|